Malmo, Sweden
CEO at Cyxone AB
Pharmaceuticals
Education
Karolinska Institutet 1979 — 1985
Doctor of Medical Science, Cellular toxicity in drug development
Umeå universitet 1970 — 1974
Master of Science, Biochemical Separation Technologies
Experience
Cyxone AB September 2015 - Present
Aptahem AB December 2014 - Present
Galecto Biotech May 2013 - Present
Accequa AB March 2012 - Present
Celus Pharmaceuticals Ltd March 2012 - Present
Biomedical Development Europe March 2011 - Present
Novation Pharmaceuticals November 2009 - Present
PCI Biotech Holding ASA May 2013 - May 2015
Nordbloom Ltd January 2011 - August 2014
Galecto Biotech December 2011 - May 2013
Skills
Regulatory Affairs, Executive Management, New Business Development, Strategy Development, Team Building, Venture Capital, Clinical Development, Public Speaking, International Business, Entrepreneurship, International Licensing, Drug Discovery, Product Development, Intellectual Property, Cross-functional Team..., Clinical Trials, Licensing, Marketing Strategy, Alliances, Contract Negotiations, Strategic Planning, Technology Transfer, Fundraising, Management Consulting, Patents, Oncology, Product Management, Contract Negotiation, Multicultural Team..., Business Strategy, Mergers, Technology..., Corporate Development, Research, Change Management, Pharmaceuticals, R&D, Commercialization, Competitive Analysis, Investments, Life Sciences, Strategic Partnerships, Start-ups, Due Diligence, Entrepreneur, Business Planning, Biotechnology, Healthcare, Medical Devices, Negotiation